The COVID-19 pandemic highlighted the need to improve the modeling, estimation, and prediction of how infectious diseases spread. SEIR-like models have been particularly successful in providing accurate short-term predictions. This study fills a notable literature gap by exploring the following question: Is it possible to incorporate a nonparametric susceptible-exposed-infected-removed (SEIR) COVID-19 model into the inverse-problem regularization framework when the transmission coefficient varies over time? Our positive response considers varying degrees of disease severity, vaccination, and other time-dependent parameters. In addition, we demonstrate the continuity, differentiability, and injectivity of the operator that link the transmission parameter to the observed infection numbers. By employing Tikhonov-type regularization to the corresponding inverse problem, we establish the existence and stability of regularized solutions. Numerical examples using both synthetic and real data illustrate the model's estimation accuracy and its ability to fit the data effectively.

The authors have declared no competing interest.

This study did not receive any funding.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors